171 related articles for article (PubMed ID: 36127534)
1. Factors Associated with Sustained Virologic Response to Hepatitis C Treatment in a Homeless-Experienced Cohort in Boston, 2014-2020.
Beiser ME; Shaw LC; Wilson GA; Muse KO; Shores SK; Baggett TP
J Gen Intern Med; 2023 Mar; 38(4):865-872. PubMed ID: 36127534
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C treatment outcomes among homeless-experienced individuals at a community health centre in Boston.
Beiser ME; Smith K; Ingemi M; Mulligan E; Baggett TP
Int J Drug Policy; 2019 Oct; 72():129-137. PubMed ID: 30962036
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C Virus Reinfection in a Real-World Cohort of Homeless-Experienced Individuals in Boston.
Beiser ME; Shaw LC; Shores SK; Carson JM; Hajarizadeh B
Clin Infect Dis; 2023 Jul; 77(1):46-55. PubMed ID: 36869823
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus care cascade in persons experiencing homelessness in the United States in the era of direct-acting antiviral agents: A scoping review.
Del Rosario A; Eldredge JD; Doorley S; Mishra SI; Kesler D; Page K
J Viral Hepat; 2021 Nov; 28(11):1506-1514. PubMed ID: 34314081
[TBL] [Abstract][Full Text] [Related]
5. Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York City.
Ziff J; Vu T; Dvir D; Riazi F; Toribio W; Oster S; Sigel K; Weiss J
Harm Reduct J; 2021 Mar; 18(1):38. PubMed ID: 33789691
[TBL] [Abstract][Full Text] [Related]
6. Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy.
Cartwright EJ; Pierret C; Minassian C; Esserman DA; Tate JP; Goetz MB; Bhattacharya D; Fiellin DA; Justice AC; Lo Re V; Rentsch CT
JAMA Netw Open; 2023 Sep; 6(9):e2335715. PubMed ID: 37751206
[TBL] [Abstract][Full Text] [Related]
7. A hepatitis C elimination model in healthcare for the homeless organization: A novel reflexive laboratory algorithm and equity assessment.
Seaman A; King CA; Kaser T; Geduldig A; Ronan W; Cook R; Chan B; Levander XA; Priest KC; Korthuis PT
Int J Drug Policy; 2021 Oct; 96():103359. PubMed ID: 34325969
[TBL] [Abstract][Full Text] [Related]
8. Shelter-Based Integrated Model Is Effective in Scaling Up Hepatitis C Testing and Treatment in Persons Experiencing Homelessness.
Khalili M; Powell J; Park HH; Bush D; Naugle J; Ricco M; Magee C; Braimoh G; Zevin B; Fokuo JK; Masson CL
Hepatol Commun; 2022 Jan; 6(1):50-64. PubMed ID: 34628726
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study.
Bajis S; Grebely J; Cooper L; Smith J; Owen G; Chudleigh A; Hajarizadeh B; Martinello M; Adey S; Read P; Gilliver R; Applegate T; Treloar C; Maher L; Dore GJ
J Viral Hepat; 2019 Aug; 26(8):969-979. PubMed ID: 30980785
[TBL] [Abstract][Full Text] [Related]
10. Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.
Galán RJ; Cidoncha EC; Martin MF; Rodriguez CC; Almeida CV; Verdugo RM
J Manag Care Pharm; 2013; 19(6):448-53. PubMed ID: 23806058
[TBL] [Abstract][Full Text] [Related]
11. Results of a Model of Delivering Hepatitis C Care in a Homeless Metropolitan Population in England.
Guerra-Veloz MF; Han K; Oakes K; Robertson D; Mohamed A; Cannon M; Barnabas A; Shah S; Halford R; Dusheiko G; Agarwal K
Am J Gastroenterol; 2023 Jun; 118(6):991-1000. PubMed ID: 36191276
[TBL] [Abstract][Full Text] [Related]
12. Sustained virologic response from hepatitis C from an emergency department screening & linkage program: A retrospective review.
Walter LA; Wilson L; Farmer M; Roberson T; Hand DT; Franco R
Am J Emerg Med; 2023 Oct; 72():178-182. PubMed ID: 37540919
[TBL] [Abstract][Full Text] [Related]
13. A multi-site, nurse-coordinated hepatitis C model of care in primary care and community services in Melbourne, Australia.
Harney BL; Whitton B; Paige E; Brereton R; Weiss R; Membrey D; Wade AJ; Iser D; Kemp W; Roberts SK; Spelman T; Sacks-Davis R; Hellard ME; Doyle JS
Liver Int; 2022 Mar; 42(3):522-531. PubMed ID: 34821021
[TBL] [Abstract][Full Text] [Related]
14. Misunderstanding of hepatitis C virus (HCV) infection status by non-specialized medical doctors in patients who achieved sustained virologic response to anti-HCV therapy.
Toyoda H; Yasuda S; Moriya A; Itobayashi E; Uojima H; Watanabe T; Atsukawa M; Arai T; Ishikawa T; Mikami S; Hiraoka A; Tsuji K; Oikawa T; Tsubota A; Nozaki A; Chuma M; Abe H; Shima T; Kumada T; Tanaka J
J Infect Chemother; 2022 Sep; 28(9):1231-1234. PubMed ID: 35534339
[TBL] [Abstract][Full Text] [Related]
15. Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort study.
Mendlowitz AB; Bremner KE; Krahn M; Walker JD; Wong WWL; Sander B; Jones L; Isaranuwatchai W; Feld JJ
CMAJ; 2023 Apr; 195(14):E499-E512. PubMed ID: 37040993
[TBL] [Abstract][Full Text] [Related]
16. Community-Based Assessment and Treatment of Hepatitis C Virus-Related Liver Disease, Injecting Drug and Alcohol Use Amongst People Who Are Homeless: A Systematic Review and Meta-Analysis.
Hashim A; Macken L; Jones A; McGeer M; Aithal G; Verma S
Int J Drug Policy; 2021 Oct; 96():103342. PubMed ID: 34210551
[TBL] [Abstract][Full Text] [Related]
17. Sustained Virologic Response Rates Before and After Removal of Sobriety Restriction for Hepatitis C Virus Treatment Access.
Martin MT; Waring N; Forrest J; Nazari JL; Abdelaziz AI; Lee TA
Public Health Rep; 2023; 138(3):467-474. PubMed ID: 35674245
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia.
Tsertsvadze T; Gamkrelidze A; Nasrullah M; Sharvadze L; Morgan J; Shadaker S; Gvinjilia L; Butsashvili M; Metreveli D; Kerashvili V; Ezugbaia M; Chkhartishvili N; Abutidze A; Kvaratskhelia V; Averhoff F
BMC Infect Dis; 2020 Jan; 20(1):30. PubMed ID: 31924172
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus micro-elimination within a clinic for people with HIV: challenges in the home stretch.
Hanna J; Sufian J; Suh JS; Jimenez HR
HIV Med; 2022 Aug; 23(7):801-806. PubMed ID: 35150183
[TBL] [Abstract][Full Text] [Related]
20. Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting.
Read P; Lothian R; Chronister K; Gilliver R; Kearley J; Dore GJ; van Beek I
Int J Drug Policy; 2017 Sep; 47():209-215. PubMed ID: 28587943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
